In a sprawling 163 page opinion issued just last week, the Connecticut Appellate Court addressed, as a matter of first impression, five different issues that will significantly affect the disposition of asbestos, and potentially other, long tail claims in Connecticut. The case, R.T. Vanderbilt Co., Inc. v. Hartford Accident and

Read More Long Tales About Long Tails – Connecticut’s Appellate Court Makes New Law

Edwards Wildman’s Robert W. DiUbaldo will participate on a panel hosted by Perrin Webinar entitled:  Sports Concussion Litigation- Latest NCAA and High School Research, Developments and Findings 
Read More Webinar: Sports Concussion Litigation- Latest NCAA and High School Research, Developments and Findings

Liability under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA, otherwise known as the Superfund statute) is strict, and in most cases joint and several.  The total cost for Superfund clean ups can range into the hundreds of millions and even billions of dollars. 
Read More Four Years Later: How Has BNSF Changed CERCLA Practice?

Edwards Angell Palmer & Dodge’s Insurance and Reinsurance Department recently published its latest Newsletter, Insurance & Reinsurance Review – March 2011, which contains nine articles about various topics in the insurance and reinsurance industry. 
Read More Insurance & Reinsurance Review – March 2011

In July 2009 in New Castle County in the State of Delaware, three separate plaintiffs filed civil suits against E. I. Du Pont De Nemours and Company, Inc. (“DuPont”) alleging that their work at a DuPont textile plant in Mercedes, Argentina from 1961 to 2002 caused them to be exposed to and inhale asbestos fibers. 
Read More U.S. Lawsuits Based Upon Foreign Toxic Tort Liability: A Growing Threat?

The 11th Circuit Court of Appeals recently relied upon the learned intermediary doctrine in affirming summary judgment in favor of Smithkline Beecham Corp. (“SBC”) in a lawsuit claiming that the antidepressant Paxil caused the decedent to commit suicide. 
Read More Learned Intermediary Doctrine: Eleventh Circuit Upholds Summary Judgment in Favor of Manufacturer in Lawsuit Claiming Antidepressant Caused Suicide

The Insurance and Reinsurance Department of Edwards Angell Palmer & Dodge is holding a 60 minute complimentary webinar entitled “Emerging Trends in Asbestos Litigation: US/UK/European Issues and Perspectives” on Tuesday, May 25, 20 at 12:00 p.m. EST. 
Read More Webinar: Emerging Trends in Asbestos Litigation: US/UK/European Issues and Perspectives

The Unites States Department of Justice is expected to announce shortly a settlement with AstraZeneca plc over allegations that the drug manufacturer improperly promoted off-label uses of its antipsychotic drug, Seroquel.  Federal and state authorities have been investigating allegations that AstraZeneca promoted the use of Seroquel for purposes not approved by the Food and Drug Administration. 
Read More $520 Million Settlement Expected in AstraZeneca Off-Label Marketing Case

A federal jury in Boston recently returned a verdict against Pfizer Inc. in connection with claims that Pfizer unlawfully promoted off-label uses of its anti-epilepsy drug Neurontin.  The plaintiffs, a group of hospitals and HMOs, claimed that Pfizer had fooled them into believing that Neurontin was effective in the treatment of bipolar disorder, neuropathic pain and other conditions. 


Read More Jury Awards $141 Million Against Pfizer in Connection With Off-Label Use of Neurontin